BUZZ-Catamaran Corp: Profit, revenue beat estimates
** Pharmacy benefit manager's U.S.-listed and Toronto-listed shares up 9 pct
** Revenue, profit beat analysts' average estimates after the company added customers and inclusion of Restat acquisition
** Q3 revenue rises more than 50 pct to $5.54 billion, beating analysts' average estimate of $5.36 billion
** Adjusted earnings of 58 cents per share, above the average estimate of 56 cents
** Company raises 2014 forecast for adjusted earnings
** U.S.-listed shares at $45.95, Toronto-listed shares at C$51.48
© Thomson Reuters 2017 All rights reserved.